Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
Titel:
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
Auteur:
Orkin, Chloe DeJesus, Edwin Sax, Paul E Arribas, Jose R Gupta, Samir K Martorell, Claudia Stephens, Jeffrey L Stellbrink, Hans-Jurgen Wohl, David Maggiolo, Franco Thompson, Melanie A Podzamczer, Daniel Hagins, Debbie Flamm, Jason A Brinson, Cynthia Clarke, Amanda Huang, Hailin Acosta, Rima Brainard, Diana M Collins, Sean E Martin, Hal